UBS upgrades Thermo Fisher Scientific stock rating on growth outlook
Covered in this story
What has happened since
- Thermo Fisher Scientific is up 9.0% since this was published, 30 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
UBS’s $730 target on $TMO is on the record and being tracked to Sep 2027 (12-month default), scored on the close that day.
UBS’s track record →Analyst targets on Thermo Fisher Scientific
- Morgan Stanley: $560 → $650 by Jul 2027 · Overweight via GuruFocus
- RBC Capital Markets: $568 → $580 by Jul 2027 via GuruFocus
- Barclays: $568 → $650 by Jul 2027 · Overweight via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $TMO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Thermo Fisher Scientific →Dalsna Finance is currently tracking 48 stories mentioning Thermo Fisher Scientific, the earliest published 23 Jul 2026.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.